Form 4: CorMedix Director Boosts Stake with Option Exercise
Insider Transaction Report
CorMedix Inc. Director Steven W. Lefkowitz acquired 15,000 shares of common stock through the exercise of vested stock options at $5.63 per share.
Summary
- Steven W. Lefkowitz, a Director of CorMedix Inc., acquired 15,000 shares of common stock on January 12, 2026.
- The acquisition was made through the exercise of fully vested stock options, which were originally granted on February 25, 2020.
- The exercise price for these shares was $5.63 per share, and the payment was made in cash.
- No sales of stock were made in connection with this transaction.
- Following the transaction, Lefkowitz directly owns 95,498 shares of CorMedix Inc. common stock.
- Indirectly, Lefkowitz beneficially owns an additional 32,152 shares, comprising 30,152 shares through the Wade Capital Corporation Money Purchase Plan and 2,000 shares through his wife.
- Beth Zelnick Kaufman was appointed as attorney-in-fact for Steven Lefkowitz on January 14, 2026, to handle his SEC filing obligations.
Sentiment
Score: 7
Explanation: The exercise of stock options by a director, without any corresponding sales, generally indicates a positive sentiment towards the company's future prospects and an increase in insider ownership.
Positives
- A director increased their direct ownership in the company by 15,000 shares, indicating confidence in CorMedix Inc.'s future.
- The exercise of options was paid in cash, demonstrating a personal investment by the insider.
- No sales of stock were made, reinforcing a positive stance on the company's prospects.
Industry Context
This filing is a routine insider transaction report and does not provide broader industry context. It reflects an individual director's investment decision rather than a company-wide strategic move.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Attorney-in-fact for SEC filings | NA | Beth Zelnick Kaufman | 01/14/2026 | Appointment by Steven Lefkowitz to handle his SEC reporting obligations. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Steven Lefkowitz granted Beth Zelnick Kaufman power of attorney to prepare, execute, submit, and file SEC Forms (ID, 3, 4, 5, 144) on his behalf as an officer and/or director of CorMedix Inc. | 01/14/2026 | Streamlines compliance with Section 16(a) of the Securities Exchange Act of 1934 for Steven Lefkowitz, ensuring timely and accurate insider transaction reporting. |
Related Party Transactions
- Steven W. Lefkowitz's indirect beneficial ownership includes 2,000 shares held by his wife.
Stakeholder Impact
- Shareholders: Increased insider ownership may be viewed positively, signaling management confidence.
Next Steps
- Steven W. Lefkowitz will continue to be subject to filing Forms 3, 4, 5, and 144 with respect to his holdings and transactions in CorMedix Inc. securities.
Key Dates
| Date | Description |
|---|---|
| 02/25/2020 | Date stock options were granted to Steven W. Lefkowitz. |
| 01/12/2026 | Date Steven W. Lefkowitz exercised 15,000 stock options. |
| 01/14/2026 | Date the Power of Attorney was executed and the Form 4 was signed by the attorney-in-fact. |
| 02/25/2030 | Expiration date of the stock options that were exercised. |
Recommendation
holdThis filing reports a routine insider transaction where a director exercised stock options and increased their ownership. While insider buying can be a positive signal, this specific transaction is an exercise of pre-existing options rather than an open market purchase, and its size relative to the company's overall market capitalization is not significant enough to warrant a strong buy or sell recommendation based solely on this filing. It reinforces a 'hold' position, as it doesn't present new fundamental information that would drastically alter the investment thesis.
Keywords
CorMedix Inc., CRMD, Steven W. Lefkowitz, Director, Stock Options, Insider Transaction, Beneficial Ownership, SEC Form 4, Equity Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.